From

Institution

Field

Type

Journal / venue: Annals of Oncology ×

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers 297

Sort: Cited Newest Oldest Fwci Patents ⇩ CSV

219P Multicentric evaluation of amplicon-based next-generation sequencing solution for local comprehensive molecular tumor profiling
2023 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

Eloisa Jantus Lewintre, Alessandra Rappa, Dina Ruano, S. Gallach Garcia, Ludovic Lacroix, Karl Kashofer, +2 more

0

citations
132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN – an EORTC-SPECTA and EURACAN study
2023 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

Marie Morfouace, Júlio Oliveira, Nicolas Penel, Julien Péron, Marc Pracht, Birutė Brasiūnienė, +14 more

0

citations
1693MO The high burden of long-term and late health-related problems among adolescent and young adult cancer survivors: Results of the SURVAYA study
2023 Annals of Oncology article Medicine Childhood Cancer Survivors' Quality of Life Open access

Carla C. P. Vlooswijk, Redmer van Leeuwen, Suzanne E. J. Kaal, Jan Martijn Kerst, M.M.E.M. Bos, Tom van der Hulle, +5 more

0

citations
1347P Peripheral osimertinib (osi) plasma trough concentration (Cmin,SS) as surrogate parameter for development and progression of brain metastasis (BM) in patients (pts) with EGFR+ advanced non-small cell lung cancer (aNSCLC)
2023 Annals of Oncology article Medicine Lung Cancer Treatments and Mutations Open access

Judith L. Gulikers, M.G.D. Veerman, M. Jebbink, Paul D. Kruithof, Christi M. J. Steendam, René J. Boosman, +9 more

0

citations
1723P Improving access to molecular tumour boards for complex genomic profiles: A healthcare policy from the Netherlands
2023 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, C. Reparon, Simone N. Koole, A. Huisman, M. van Aart, W. Groenen, +6 more

0

citations
1123P Baseline tumor-infiltrating lymphocytes and response to immune checkpoint inhibition in advanced melanoma
2023 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Mark Schuiveling, I. van Duin, Laurens S. ter Maat, Franchette W.P.J. van den Berkmortel, M. J. Boers‐Sonderen, Jan Willem de Groot, +11 more

0

citations
904P Retrospective analysis of adjuvant systemic anti-hormonal therapy for resected androgen receptor-positive (AR+) salivary duct carcinoma (SDC)
2023 Annals of Oncology article Medicine Salivary Gland Tumors Diagnosis and Treatment Open access

Jetty A.M. Weijers, Gerald W.C.T Verhaegh, C.M.L. Driessen, Ilse van Engen‐van Grunsven, Lot A. Devriese, Marije Slingerland, +3 more

0

citations
781P Chemotherapy sensitivity score based on ex vivo 3D tumour testing to predict clinical response for ovarian cancer patients
2023 Annals of Oncology article Medicine Ovarian cancer diagnosis and treatment Open access

Cor Doede de Kroon, Anne M. van Altena, Dieudonne J. van der Meer, L. Ceton, Timothy J. P. Sijsenaar, F. Grillet, +4 more

0

citations
1575P Factors associated with uptake of adjuvant nivolumab in a nationwide esophageal cancer patient cohort
2023 Annals of Oncology article Medicine Esophageal Cancer Research and Treatment Open access

Rob H.A. Verhoeven, Nadia Haj Mohammad, Pauline A. J. Vissers, David Bertwistle, Prianka Singh, Mark I. van Berge Henegouwen, +11 more

0

citations
1918MO Circulating tumor DNA in relation to tumor volume in gastro-intestinal stromal tumors
2023 Annals of Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access

Roos F. Bleckman, Christian Haag, Ron H.J. Mathijssen, Neeltje Steeghs, Hans A. J. Gelderblom, Ingrid M.E. Desar, +3 more

0

citations
520P Guidelines for time-to-event endpoints in gastrointestinal cancer using real-world data
2024 Annals of Oncology article Mathematics Statistical Methods in Clinical Trials Open access

P.A. Vissers, Marloes A.G. Elferink, B. Bonsing, L. Vandergeest, M. Koopman, Hanneke W.M. van Laarhoven, +9 more

0

citations
465P Timing of first-line palliative systemic therapy in metastatic Esophagogastric cancer (mEGC): A European Delphi study
2024 Annals of Oncology article Medicine Gastric Cancer Management and Outcomes Open access

Denice Kamp, A.M. May, Antoine Adenis, A. Capela Marques, Sarah Derks, F. Defelice, +14 more

0

citations
1140TiP Safe stop IPI-NIVO trial: Early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab
2024 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Brigit van Dijk, Karlijn de Joode, MJB Aarts, Franchette W.P.J. van den Berkmortel, C.U. Blank, M. J. Boers‐Sonderen, +13 more

0

citations
1737P A comparison of the risk prediction models sarculator and PERSARC in patients with localized soft tissue sarcoma of the extremities and trunk wall
2024 Annals of Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

M.R. Kobbeltvedt, Ingvild V. K. Lobmaier, Marta Spreafico, Fatih Kızılaslan, Ivar Hompland, Sandro Pasquali, +4 more

0

citations
1262P Combined molecular analysis of circulating tumour DNA and tumour tissue to identify osimertinib resistance
2024 Annals of Oncology article Medicine Lung Cancer Treatments and Mutations Open access

Twan van der Wel, M. Jebbink, Sushil K. Badrising, Laurie C. Steinbusch, Gerrina Ruiter, Willemijn S.M.E. Theelen, +12 more

0

citations
CN22 Remote patient monitoring using mHealth technology in cancer care and research: Patients’ perspectives, willingness, and current use
2024 Annals of Oncology article Medicine Telemedicine and Telehealth Implementation Open access

Dominique G. Stuijt, M. Kos, Eva E.M. van Doeveren, I. Dingemans, Carol Richel, Marijn Eversdijk, +3 more

0

citations
130P Ipilimumab plus nivolumab (Ipi+Nivo) in patients with tumors harboring high tumor mutational burden or load (TMB/TML-H): Results from the Drug Rediscovery Protocol (DRUP)
2024 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Soemeya F. Haj Mohammad, L.J. Zeverijn, B.S. Geurts, Ilse A.C. Spiekman, P. Roepman, Anna Jansen, +5 more

0

citations
1770P Safety, efficacy, and patient-reported outcomes (PROs) with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received prior anti–colony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study
2024 Annals of Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access

Andrew J. Wagner, Kristen N. Ganjoo, S. Stacchiotti, Hans A. J. Gelderblom, Christina Ryan, E. Palmerini, +10 more

0

citations
1769P Safety and efficacy with vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT) who received no prior anti–colony-stimulating factor 1 (CSF1) therapy: Ongoing phase II study
2024 Annals of Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access

C. Serrano, Jean‐Yves Blay, P. Rutkowski, Hans A. J. Gelderblom, S. Stacchiotti, A. Falcon Gonzalez, +12 more

0

citations
1747P Changes in global health status (GHS) in patients with advanced soft tissue sarcoma (STS) treated with first line palliative chemotherapy: Primary outcomes from the HOLISTIC study
2024 Annals of Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

Evelyne Roets, Eugenie Younger, Robin L. Jones, Dide den Hollander, Leyla Azarang, I. Desar, +6 more

0

citations
1738P Results from the conference on challenges in sarcoma (CCS) 2024
2024 Annals of Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

Christian Alexander Rothermundt, Chantal Pauli, Aisha B Miah, Wolfgang Gerhard Kunz, Eva Wardelmann, P. Rutkowski, +5 more

0

citations
1644P PSA trajectories and prediction of time to no-longer clinically benefitting in metastatic castration-resistant prostate cancer: Insights from the ProBio trial
2024 Annals of Oncology article Medicine Prostate Cancer Treatment and Research Open access

Linda Broer, Jan Oldenburg, Ashkan Mortezavi, Johan Lindberg, A. Discacciati, Camilla Thellenberg Karlsson, +13 more

0

citations
769P The prognostic impact of CDKN2A/B heterozygous deletions in meningioma-insights of a multicenter analysis
2024 Annals of Oncology article Medicine Meningioma and schwannoma management Open access

Franziska Maria Ippen, Thomas Hielscher, Sybren L. N. Maas, Andreas von Deimling, Wolfgang Wick, Abigail Kora Suwala, +1 more

0

citations
1883P Blood based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: The prospective IOpener study
2025 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Karlijn de Joode, Harry J.M. Groen, Jeroen S. Kloover, Cor van der Leest, Ben van den Borne, R. de Wijn, +9 more

0

citations
1156P Transcriptomic analysis in p53-abnormal endometrial cancer and final overall survival analyses from the DOMEC phase II trial
2025 Annals of Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

Merve Kaya, Cathalijne Post, Nadia de Gruil, Siddh van Oost, Jacqueline Maria Tromp, IA Boere, +11 more

0

citations